Send feedback

GNPTAB p.Phe53fs

c.157_160del · rs794727302 · VCV195376

Pathogenic/Likely pathogenic Multiple submitters
Classification
Pathogenic/Likely pathogenic
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 3 submitters
Consequence
frameshift
predicted LoF
gnomAD v4.1
Rare
very rare (popmax 0.0011%, nfe)
Conditions
2
mucolipidosis type II

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Consequenceframeshiftpredicted loss-of-function
NMDpredictedpremature termination codon in exon 2 of 21
Splicing
SpliceAI—not assessed · substitutions only
Constraint at this position
ConservationphyloP 7.7GERP 2.5, phastCons 1

Predicted loss-of-function is descriptive, not an applied PVS1 code.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0011% European (non-Finnish) · 13/1,179,440 alleles
Filtering AF 0.000615% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.000474%
Overall 0.000868% 14/1,613,272 alleles · very rare exomes 14/1,460,966 · genomes 0/152,306 · joint denominator
Ancestry group Frequency 1 in
Remaining individualsnot grpmax-eligible 0.0016% 62,478
European (non-Finnish)grpmax 0.0011% 90,726

Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
GNPTAB
Protein
p.Phe53fs
Coding
c.157_160del
MANE Select
NM_024312
dbSNP
rs794727302
Type
Microsatellite
Location
chr12:101796720 (GRCh38)
Gene constraint
LOEUF 0.8 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 72.15 · 5 PDB
Residue 53
an α-helix
Full GNPTAB gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

mucolipidosis type II — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Also linked: mucolipidosis type III, alpha/beta

For Mucolipidosis type II (Orphanet):

Inheritance
Autosomal recessive
Onset
Antenatal, Neonatal
Prevalence
1-9 / 1 000 000 (Europe)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/gnptab-p-phe53fs (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown